US Broker Ratings

Harmony Biosciences (HRMY): A Promising Biotech with a 67% Potential Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) has caught the attention of investors with its significant potential upside of 67.53%, according to analyst ratings. As a key..

Select Medical Holdings Corp (SEM): Analyst Ratings Signal 33% Upside Potential in Healthcare Sector

Select Medical Holdings Corporation (NYSE: SEM) stands as a significant player in the U.S. healthcare industry, specializing in critical illness recovery, rehabilitation hospitals, and outpatient rehabilitation..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: A Biopharma Gem with 27.60% Upside Potential

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA), a dynamic player in the biopharmaceutical landscape, is capturing the attention of investors with its promising pipeline and steady revenue growth...

NovoCure Limited (NVCR) Stock Analysis: A Closer Look at an 87.5% Potential Upside in the Medical Device Sector

NovoCure Limited (NVCR), a pioneering oncology company based in Baar, Switzerland, is making waves in the healthcare sector with its innovative tumor treating fields (TTFields) technology...

CRISPR Therapeutics AG (CRSP) Stock Analysis: Examining the 15.4% Potential Upside in Revolutionary Gene Editing

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering entity in the gene editing space, stands at a compelling intersection of biotechnology and groundbreaking medical solutions. With a..

QuidelOrtho Corporation (QDEL) Stock Analysis: Navigating a 36.26% Potential Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL), a key player in the healthcare sector specializing in medical devices, offers an intriguing proposition for investors navigating the complex diagnostics landscape...

Organon & Co. (OGN) Stock Analysis: Strong Upside Potential Amid Volatile Market Dynamics

Organon & Co. (NYSE: OGN), a prominent player in the healthcare sector, specifically within the general drug manufacturing industry, offers an intriguing investment opportunity for those..

LivaNova PLC (LIVN) Stock Analysis: Navigating a 23% Potential Upside in the Healthcare Sector

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with a compelling 23.31% potential..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 46.51% Potential Upside for Investors

ICU Medical, Inc. (NASDAQ: ICUI), a key player in the healthcare sector specializing in medical instruments and supplies, presents an intriguing opportunity for investors. With a..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: Exploring a 20% Upside Potential in the Biotech Sector

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is making waves in the biotechnology sector with a market capitalization of $5.18 billion and a current stock price of $37.50...

Crinetics Pharmaceuticals (CRNX) Stock Analysis: An Ambitious Biotech with a 92.58% Upside Potential

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a San Diego-based biotechnology company, has garnered significant attention in the investment community, thanks to its innovative approach to treating rare..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: Uncovering a 53.71% Potential Upside in Biotech

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) stands as a fascinating player in the biotechnology sector, with a market capitalization of $3.08 billion. Based in Waltham, Massachusetts, Apellis..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Is a 50% Upside on the Horizon?

For investors with an eye on the healthcare sector, LifeStance Health Group, Inc. (NASDAQ: LFST) presents a compelling opportunity, particularly given its significant potential upside of..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Exploring a Potential 185.92% Upside for Biotech Investors

Viking Therapeutics, Inc. (NASDAQ: VKTX) stands out in the biotechnology sector with a market cap of $3.63 billion. Headquartered in the United States, the company is..

Immunovant, Inc. (IMVT) Stock Analysis: Examining the 141% Potential Upside in Biotech Innovation

For investors with an appetite for risk and a keen interest in the biotechnology sector, Immunovant, Inc. (NASDAQ: IMVT) presents a compelling case with its significant..

Concentra Group Holdings Parent (CON) Stock Analysis: Strong Buy Ratings and 36% Potential Upside

Concentra Group Holdings Parent, Inc. (CON), a notable player in the healthcare sector, particularly within the medical care facilities industry, is drawing attention from individual investors...

Sotera Health Company (SHC) Investor Outlook: Analyzing the Stock’s Resilience Amid Healthcare Sector Dynamics

Sotera Health Company (NASDAQ: SHC) stands out in the healthcare sector’s diagnostics and research industry, offering a robust array of services that include sterilization, lab testing,..

Perrigo Company plc (PRGO) Stock Analysis: Evaluating the 55% Upside Potential

As investors navigate the ever-evolving landscape of healthcare stocks, Perrigo Company plc (NYSE: PRGO) emerges as a notable consideration. Operating within the Drug Manufacturers – Specialty..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Insights Into Its 11.91% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) is a notable player in the healthcare sector, specifically within the biotechnology industry, with its headquarters in Pittsburgh, Pennsylvania. As a..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with Significant Growth Potential

TG Therapeutics, Inc. (NASDAQ: TGTX) is drawing considerable attention in the biotechnology sector, with its market cap reaching an impressive $5.82 billion. This commercial-stage biopharmaceutical company,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds